期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | CANCER IMMUNOLOGY IMMUNOTHERAPY LetPub Score 7.7
50 ratings
Rate
Reputation 8.8 Influence 6.5 Speed 8.9 | ||||||||||||||||||||||||||||
期刊簡稱 | CANCER IMMUNOL IMMUN | ||||||||||||||||||||||||||||
ISSN | 0340-7004 | ||||||||||||||||||||||||||||
E-ISSN | 1432-0851 | ||||||||||||||||||||||||||||
h-index | 104 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | https://www.springer.com/262 | ||||||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/ciim | ||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||
出版商 | Springer Berlin Heidelberg | ||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||||||
創刊年 | 1976 | ||||||||||||||||||||||||||||
每年文章數 | 207每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 37.57% | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0340-7004%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 1 Month(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[CANCER IMMUNOLOGY IMMUNOTHERAPY] 的評論 | 撰寫評論 |
作者: 九嶷 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-06-05 16:55:39 評論於 A review article on tumor immunity, Molecular Cancer, was rejected by one major revision editor before being submitted directly to this journal. It was submitted at the end of February and accepted in early June, with only minor revisions required. Overall, I didn't find it very difficult, similar to the past two years of experience with FII. Both the first round and second round of reviews had one reviewer whose review time exceeded a month, but the feedback provided was relatively simple. There was no feedback during the second round of review, and I was directly notified of acceptance. ![]() ![]() |
作者: 岁月易逝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-02-08 10:17:26 評論於 The assistant replied after reminding, but there was no change, and it has been almost a month. ![]() ![]() |
作者: Kile 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-02-06 20:20:29 評論於 How fast is the first instance trial going? ![]() ![]() |
作者: Kile 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-02-06 20:19:55 評論於 The person who replied is not the editor in charge of your manuscript, but a similar assistant editor. You can ask him to follow up with the editor in charge of your manuscript. ![]() ![]() |
作者: 岁月易逝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-01-23 10:49:54 評論於 Do any of you fellow writers who have experience with follow-up responses have any suggestions? If withdrawing the submission is necessary, can I simply send an email? This process is taking too long. ![]() ![]() |
作者: 岁月易逝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-01-02 08:44:44 評論於 The speed is too slow, it has been two months since submission and still no reviewers have been assigned. It's so frustrating. Be cautious when submitting for graduation. ![]() ![]() |
作者: CCCCZ123 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-11-27 14:57:56 評論於 The first review was very fast, and it came back in less than a month. It was for major revisions, with five comments from the reviewer. It has been over a month since the second review, and the reviewer has not accepted the manuscript yet. I would like to ask fellow authors who have submitted, how long will the editor wait before moving on to the next step? ![]() ![]() |
作者: 虎鹤启峰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-25 18:03:54 評論於 Research focus: Tumor immunotherapy Experience sharing: The editor has not invited reviewers for review and has not provided a refund. It has been about 2 weeks in the editor's hands. ![]() ![]() |
作者: 四风碧芙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-16 22:43:52 評論於 Where can I see how many reviewers have been invited, thank you ![]() ![]() |
作者: 一条小友容 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-29 21:56:07 評論於 About how long does it take to receive the proof? It has been over a week and I have not received it yet ![]() ![]() |
作者: 雨巷少年印枝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-10 22:58:20 評論於 Please translate the following paragraph into English and Japanese ![]() ![]() |
作者: 长文小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-31 08:50:04 評論於 What's going on, how can a 6-point non-OA journal be listed in the third district, it's really outrageous ![]() ![]() |
作者: 天霜天罡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-23 08:23:24 評論於 Review speed: 4.0 Emphasis on Research Direction: Immunology; Tumor Immunology Experience to Share: Achieved Tier 3, not cost-effective ![]() ![]() |
作者: 般若沛旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-11 17:41:30 評論於 I haven't found the reviewer yet, once found it will be waiting for the reviewer's report ![]() ![]() |
作者: Tracy Byron 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-09 15:14:37 評論於 Please translate the following paragraph into English and Japanese, and title them ":" and ":" ![]() ![]() |
作者: 努力啊大雪绿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-06 17:28:39 評論於 Hello, may I ask what the indication is when a review is in the reviewing status? Mine has been stuck at "31 reviewers invited" and I'm not sure if it's in review or if reviewers have not been found yet ![]() ![]() |
作者: 天霜天罡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-25 09:11:46 評論於 Hello, have you received any news? I have been looking for a reviewer for three months, but I still haven't received any response to my emails ![]() ![]() |
作者: 天霜天罡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-22 21:34:17 評論於 Congratulations! I urge the editor, too slow ![]() ![]() |
作者: 般若沛旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-19 15:10:00 評論於 My today has been officially received. You can write a reminder letter again. We wrote three times, and later they were all processed quickly ![]() ![]() |
作者: 魔都代瑶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-11 18:08:42 評論於 +1, I also don't have permission to access the interface ![]() ![]() |
作者: 朝阳超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-06 12:44:59 評論於 Review Speed: 6.0 | Acceptance Rate: 25.0 Sharing Experience: It took 4 months to find reviewers with no response at all, very slow, and don't know how to withdraw the submission ![]() ![]() |
作者: 天霜天罡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-02 19:44:20 評論於 11 Reviewer(s) invited for almost two months ![]() ![]() |
作者: 访儿小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-24 17:57:23 評論於 Does anyone know why the submission page shows "you do not have sufficient permissions to view this page"? ![]() ![]() |
作者: 访儿小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-19 23:44:25 評論於 Can I submit my application now? It shows that I do not have the permission ![]() ![]() |
作者: 访儿小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-18 21:18:38 評論於 Have you encountered the message that you do not have permission to access the submission page? Why don't you have permission? ![]() ![]() |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us